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ABSTRACT
Crotonaldehyde is a representative a,b-unsaturated
aldehyde endowed of mutagenic and carcinogenic
propertiesrelatedtoitspropensitytoreactwithDNA.
Cyclic crotonaldehyde-derived deoxyguanosine
(CrA-PdG) adducts can undergo ring opening in
duplex DNA to yield a highly reactive aldehydic
moiety. Here, we demonstrate that site-specifically
modified DNA oligonucleotides containing a single
CrA-PdG adduct can form crosslinks with topo-
isomerase I (Top1), both directly and indirectly.
Direct covalent complex formation between the
CrA-PdG adduct and Top1 is detectable after reduc-
tion with sodium cyanoborohydride, which is con-
sistent with the formation of a Schiff base between
Top1 and the ring open aldehyde form of the adduct.
In addition, we show that the CrA-PdG adduct alters
the cleavage and religation activities of Top1. It
suppresses Top1 cleavage complexes at the adduct
site and induces both reversible and irreversible
cleavage complexes adjacent to the CrA-PdG
adduct. The formation of stable DNA–Top1 cross-
links and the induction of Top1 cleavage complexes
by CrA-PdG are mutually exclusive. Lastly, we found
that crotonaldehyde induces the formation of DNA–
Top1complexesinmammaliancells,whichsuggests
a potential relationship between formation of DNA–
Top1 crosslinks and the mutagenic and carcinogenic
properties of crotonaldehyde.
INTRODUCTION
Crotonaldehyde is a rather simple a,b-unsaturated alde-
hyde (enal) that is ubiquitous in the human environment.
The general population is exogenously exposed to
crotonaldehyde through mobile source emissions, tobacco
smoke and other thermal degradation mixtures (1). It is
also produced endogenously from lipid peroxidation (2)
and from the metabolism of N-nitrosopyrrolidine (3,4).
Crotonaldehyde has been shown to be mutagenic in both
Salmonella typhimuruim (5,6) and human lymphoblasts
(7). Site-speciﬁc mutagenesis revealed that the crotonalde-
hyde-dG adducts are modestly mutagenic in COS7 cells as
well (8). In addition, crotonaldehyde has been found to
induce liver tumors in rats (9) and is regarded as a possible
human carcinogen.
Both the mutagenic and carcinogenic eﬀects of croton-
aldehyde exposure have been proposed to be associated
with the ability of crotonaldehyde to react covalently with
DNA. Crotonaldehyde as well as other structurally related
a,b-unsaturated aldehydes produce cyclic l,N
2-deoxygua-
nosine (dG) adducts in vitro. The reaction mechanism
involves nucleophilic Michael addition by the exocyclic
N
2 atom of dG to the carbon–carbon double bond of the
enal, and subsequent ring closure by reaction of the
carbonyl carbon atom with the N1 position of dG (10–12).
The resulting products from a reaction between croton-
aldehyde and dG are a pair of diastereomeric adducts,
R- and S-a-methyl-g-hydroxy-1,N
2-propano-20-deoxygua-
nosine (R- and S-CrA-PdG) (11). Several methods have
been developed and used successfully to detect these types
of DNA adducts in vivo (13–17). In addition, the recent
syntheses of DNA oligonucleotides containing site- and
stereo-speciﬁc CrA-PdG adducts has enabled their chem-
istry and biology to be further studied in vitro (18,19). For
instance, positioning the cyclic CrA-PdG adduct opposite
dC in duplex DNA has been shown to promote ring
opening to the corresponding aldehydic form of the CrA-
PdG adduct (N
2-[3-oxo-1-methyl-propyl]-dG) (20). The
unveiling of the aldehyde moiety within a DNA duplex
allows for secondary reactions, including the formation of
interstrand DNA–DNA crosslinks to the N
2-position of
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well as DNA–peptide (23) and DNA–protein crosslinks
(24). Interestingly, the formation of interstrand DNA–
DNA crosslinks are dependent on the adduct stereochem-
istry (25,26), whereas the crosslinking eﬃciency to the
tetrapeptide KWKK is similar between the diastereomeric
R- and S-CrA-PdG adducts (23).
As mentioned above, earlier studies have established the
DNA–protein crosslinking potential of CrA-PdG adducts
with a limited selection of short peptides. Therefore, to
expand on these previous studies, we initially sought to
obtain evidence for the existence of DNA–protein cross-
linked species between the crotonaldehyde-derived DNA
adduct and cellular proteins, speciﬁcally DNA topoisom-
erase I (Top1). In a second set of experiments, we examine
the consequences of the CrA-PdG adducts on the DNA
cleavage/religation activity of Top1. Lastly, we assess the
ability of crotonaldehyde to stimulate the formation of
DNA–Top1 covalent complexes in cultured mammalian
cells.
MATERIALS AND METHODS
Synthesis ofmodified oligonucleotides
Oligonucleotide containing the crotonaldehyde-dG adduct
was prepare via a postoligomerization strategy as pre-
viously described and characterized by MALDI-MS using
a 3-hydroxypicolinic acid matrix containing ammonium
hydrogen citrate (7mg/ml) to suppress multiple sodium
and potassium adducts (19). Brieﬂy, a 22-mer oligo-
nucleotide was prepared containing an O
6-(2-trimethylsi-
lylethyl)-2-ﬂourohypoxanthine base (50-AAAAATTTT
TCCAAG TCTTTTT-30, where G  denotes the modiﬁed
nucleotide) from the corresponding modiﬁed phosphor-
amidite reagent using standard solid-phase DNA synthesis
protocols. This modiﬁed oligonucleotide was deprotected
as previously described and puriﬁed by HPLC using
gradient 1 (MALDI-MS: found 6774.8; calc’d 6773.3).
Displacement of 2-ﬂuoro group with racemic 2-amino-4,
5-dihydroxypentane provided the corresponding oligo-
nucleotide, where G  is N
2-(1-methyl-4,5-dihydroxybutyl)-
dG which was puriﬁed by HPLC using gradient
2 (MALDI-MS: found 6773.0; calc’d 6772.2). The vicinal
diol was oxidized with sodium periodate to aﬀord the
22-mer oligonucleotide containing a mixture of the R- and
S-crotonaldehyde-dG adducts. The diastereomeric oligo-
nucleotides were separated by HPLC using gradient
3 (MALDI-MS for the R-isomer: 6742.8.0; calc’d 6740.2;
S-isomer: found 6743.3; calc’d 6740.2). The speciﬁc
isomers were identiﬁed by enzymatic digestion and
identiﬁcation of the modiﬁed nucleoside by coinjection
with authentic standards of known stereochemistry (19).
HPLC
Puriﬁcation of the modiﬁed oligonucleotides were per-
formed on a Beckman HPLC system (32Karat software
version 3.1, pump module 125) with a diode array UV
detector (module 168) monitoring at 260nm using Waters
YMC ODS-AQ column 250mm 10mm i.d., 5ml/min
with 0.1M aqueous ammonium formate and CH3CN for
oligonucleotides. HPLC gradient: (i) a linear gradient
from 1% to 10% acetonitrile over 15min, then a linear
gradient from 10% to 20% acetonitrile over 10min, then a
linear gradient from 20% to 100% acetonitrile over 3min,
then isocratic at 100% acetonitrile for 2min, followed by a
linear gradient back to 1% acetonitrile over 3min; (ii) a
linear gradient from 1% to 10% acetonitrile over 15min,
then a linear gradient from 10% to 13% acetonitrile over
10min, then a linear gradient from 13% to 80%
acetonitrile over 3min, then isocratic at 80% acetonitrile
for 2min, followed by a linear gradient back to 1%
acetonitrile over 3min; (iii) a linear gradient from 1% to
9.2% acetonitrile over 5min, then a linear gradient from
9.2% to 13.2% acetonitrile over 30min, then a linear
gradient from 13.2% to 99% acetonitrile over 2min, then
isocratic at 99% acetonitrile for 1min, followed by a linear
gradient back to 1% acetonitrile over 2min.
Preparation and end-labeling of oligonucleotide substrates
Oligonucleotides were either 50-end labeled using T4 poly-
nucleotide kinase and [g-
32P] ATP (crosslinking assay)o r
30-end labeled using terminal deoxynucleotidyl transferase
(TdT) and [a-
32P] ddATP (Top1 cleavage assay), respec-
tively. Unincorporated radioactive nucleotides were
removed using a mini Quick Spin Oligo column (Roche,
Indianapolis, IN, USA) after inactivation of the kinase or
TdT by heating for 5min at 958C. For construction of
double-stranded oligonucleotides, labeled single-stranded
oligonuceotides were annealed with their complementary
strand by heating for 5min at 958C and slowly cooling to
room temperature.
Borohydride trappingof DNA–Top1 crosslinks
Both crotonaldehyde-derived deoxyguanosine adducted
DNA substrates and nonadducted DNA substrates were
incubated with recombinant Top1 in the presence or
absence of 50mM NaCNBH3 for 15min at 258Ci na
reaction buﬀer containing 10mM Tris–HCl (pH  7.5),
50mM KCl, 5mM MgCl2, 0.1mM EDTA, 15mg/ml BSA
and 0.2mM DTT. NaCNBH3 was prepared on the day of
use and added to each reaction immediately preceding the
addition of Top1. Reactions were terminated by the
addition of one volume of Tris/Glycine/SDS loading
buﬀer. Samples were resolved on a 4–20% sodium dodecyl
sulfate (SDS)–polyacrylamide gel in the presence of 1 
Tris/Glycine/SDS buﬀer for  1h at 100V. Results were
visualized by PhosphorImager analysis.
Top1-mediated DNA cleavage reactions
DNA substrates were incubated with recombinant Top1
in the presence or absence of camptothecin and/or 50mM
NaCNBH3 for 20min at 258C in a reaction buﬀer
containing 10mM Tris–HCl (pH  7.5), 50mM KCl,
5mM MgCl2, 0.1mM EDTA, 15mg/ml BSA and 0.2mM
DTT. Reactions were terminated by the addition of SDS
(ﬁnal concentration of 0.5%). An equal volume of loading
buﬀer (80% formamide, 1mM EDTA, 10mM NaOH,
0.1% xylene cyanol, 0.1% bromphenol blue) was added.
The samples were subsequently heated to 958C for 5min
and analyzed on a 20% sequencing polyacrylamide gel.
Nucleic Acids Research, 2008, Vol. 36, No. 12 4129For reversal experiments, the addition of SDS was
preceded by the addition of NaCl (ﬁnal concentration of
0.35M at 258C for the indicated times).
Detectionof DNA–Top1 covalentcomplexes inMCF7 cells
DNA–Top1 covalent complexes were isolated using the
immunocomplex of enzyme (ICE) bioassay as previously
described (27,28). Brieﬂy, 1 10
6 MCF7 cells treated
with drug or untreated were immediately lyzed with 1%
sarkosyl. After homogenization with a Dounce homo-
genizer, cell lysates were gently layered on CsCl step
gradients and centrifuged at 165000g for 20h at 208C.
Half-milliliter fractions were collected, diluted with an
equal volume of 25mM sodium phosphate buﬀer (pH 6.5)
and applied to Immobilon-P membranes by using a slot-
blot vacuum manifold. DNA–Top1 complexes were
detected using the C21 Top1 monoclonal antibody and
standard western blotting procedures. Experiments were
done independently at least twice.
RESULTS
Covalent trappingof topoisomerase Iat the CrA-PdG
adduct induplex DNA
To evaluate the propensity of the crotonaldehyde-derived
dG adducts to crosslink to Top1, we incorporated a single
CrA-PdG adduct into a previously identiﬁed 22-bp DNA
oligonucleotide sequence that contains a single high-
aﬃnity Top1 cleavage site (29–31). As shown in
Figure 1A, the CrA-PdG adduct was placed on the
nonscissile strand at the  3 position relative to the Top1
cleavage site. In order to assay for crosslink formation
between Top1 and oligonucleotides carrying such an
adduct, we adapted the borohydride trapping approach
previously employed by Krutz and Lloyd (23). In this
assay,
32P-labeled DNA substrates are incubated with the
protein of interest under reducing conditions, i.e. in the
presence of sodium cyanoborohydride (NaCNBH3).
The samples are then separated using denaturing SDS–
polyacrylamide gel electrophoresis. DNA–protein cross-
links appear as radiolabeled species that migrate slower
than the substrate DNA.
The data in Figure 1B show that Top1 did not yield
detectable crosslinks with the DNA substrates lacking the
CrA-PdG adduct (lanes 1–6). The single-stranded CrA-
PdG-adducted DNA substrate also did not generate
DNA–Top1 crosslinks (Figure 1B, lanes 7–9), which is
to be expected given that recent studies have shown the
CrA-PdG adduct exists in the nonreactive ring-closed
structure in single-stranded DNA (26). In contrast, the
formation of the reactive ring-open conformation of the
CrA-PdG adduct occurs in the duplex DNA substrate and
is thus able to form DNA–Top1 crosslinks, as evidenced
by the appearance of a new band having retarded mobility
in Figure 1B (lane 12). The band ascribed to the DNA–
Top1 crosslink can only be observed after reduction of
the complex by NaCNBH3 treatment, suggesting that
Top1 forms a transient Schiﬀ base intermediate with the
CrA-PdG adduct. In addition, the yield of the band
corresponding to the DNA–Top1 crosslink was also
dependent on the amount of Top1 in the reaction
(Figure 1C). These results support as well as extend
previous studies, which observed that the ring opening of
the CrA-PdG adduct to form a reactive aldehyde was
required for crosslink formation (20,23).
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Figure 1. Covalent trapping of the DNA–protein crosslink formed between Top1 and a double-stranded DNA oligonucleotide containing a CrA-
PdG adduct. (A) Shown is the sequence of the 22-bp oligonucleotide used in the study. The position of the CrA-PdG adduct is indicated by
a box and asterisk on the lower strand. The positions of the high aﬃnity Top1 cleavage site and the
32P-radiolabel are also shown. (B) Both single-
stranded (ss) and double-stranded (ds) control (WT) or R/S-CrA-PdG (R/S) adducted oligonucleotides were incubated at 258C for 15min in the
presence or absence of Top1 (250nM). NaCNBH3 (50mM) was added to reactions as indicated. (C) Reactions were carried out exactly as described
in (B) with the double-stranded R/S-CrA-PdG (R/S) adducted oligonucleotide in the presence of increasing amounts of Top1 (25, 50, 100, 250 and
500nM) and the presence of NaCNBH3 (50mM). All reaction products were resolved through SDS–PAGE (4–20%) analysis. Arrows indicate the
positions of the DNA–Top1 crosslink and the free DNA substrate.
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adducts induplex DNA is independent ofstereochemistry
Recent NMR studies of the individual R- and S-CrA-PdG
adducts have shown that the ring open conformation of
the CrA-PdG adduct in duplex DNA is located in the
minor groove with the aldehyde functionality oriented in
the 50- and 30-direction, respectively (Figure 2A and 2B)
(26). The initial borohydride trapping studies were
performed using DNA substrates containing a mixture
of the R- and S-CrA-PdG diastereomers. In order to
investigate the possible stereospeciﬁc formation of DNA–
Top1 crosslinks by CrA-PdG adducts, the R- and S-CrA-
PdG adducted oligonucleotides were separated and
independently subjected to the borohydride trapping
assay. As shown in Figure 2C, no signiﬁcant diﬀerences
were detected in the formation of DNA–Top1 crosslinks
between the mixture and the DNA substrates containing
the individual diastereomers. In addition, similar results
were obtained when comparing the rates of crosslink
formation for the R- and S-CrA-PdG adducted DNA
substrates (Figure 2D). These results also corroborate
previous studies, which demonstrated the formation of
DNA–peptide crosslinks were independent of the CrA-
PdG adduct stereochemistry (20).
The presence ofaCrA-PdG adduct redirects the
Top1-mediated DNA cleavage
The consequences of the CrA-PdG adduct on Top1-
mediated DNA cleavage were examined. Since Top1
becomes covalently linked to the 30-DNA end, the DNA
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Figure 2. DNA–Top1 crosslinking capacity of the isolated diastereomeric R- and S-CrA-PdG adducts. (A) Chemical structures of the crotonaldehyde
derived R- and S-CrA-PdG adducts. (B) Molecular model and NMR structrure of the R- and S-CrA-PdG adducts, respectively, showing the
orientations of the reactive aldehyde moieties and a-carbon methyl groups within the minor groove of the DNA. DNA shown in blue; CrA portion
of adduct shown in green; oxygen from the aldehyde moiety shown in red. (C) Double-stranded (ds) control (WT), R/S-, R-, or S-CrA-PdG adducted
oligonucleotides were incubated with increasing amounts of Top1 (50 and 250nM) at 258C for 15min in the presence of NaCNBH3 (50mM).
(D) Double-stranded R- and S-CrA-PdG adducted oligonucleotides were incubated with Top1 (250nM) at 258C for 1, 2, 5, 10 and 15min in the
presence of NaCNBH3 (50mM). All reaction products were resolved through SDS–PAGE (4–20%) analysis.
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32P]ddATP in order
to unambiguously assign the positions of the cleavage
products generated by Top1 (shown in Figure 3B). As
previously demonstrated (32,33), Top1 did not produce
detectable cleavage in the unmodiﬁed DNA substrate
(Figure 3A, lane 2); however, in the presence of the Top1
inhibitor camptothecin (CPT), the expected 13-mer clea-
vage product was observed (Figure 3A, lanes 3 and 4) (32).
When the CrA-PdG adduct was present at the  3(G)
position on the nonscissile strand, an alteration in the
Top1-mediated DNA cleavage was detected. Speciﬁcally,
two new Top1 cleavage products, which corresponded to
17-mer and 18-mer fragments labeled at the 30-end (see
sequence in Figure 3B), were produced that did not require
CPT (Figure 3A, lane 10). The CrA-PdG adduct also
completely suppressed the expected CPT-induced 13-mer
cleavage product (Figure 3A, lanes 11 and 12). Of the two
new Top1 cleavage products generated by the CrA-PdG
adduct, only the 18-mer fragment was enhanced upon the
addition of CPT (Figure 3A, lanes 11 and 12). Similar
results were obtained with the DNA substrates containing
the individual R- and S-CrA-PdG diastereomers (data not
shown).
The cleavage reactions were also carried out under
reducing conditions so as to monitor the eﬀects of DNA–
Top1 crosslink formation by CrA-PdG adducts on Top1-
mediated DNA cleavage. The comparison of lanes 1–4
and lanes 5–8 in Figure 3A demonstrates that the presence
of NaCNBH3 results in only a minor reduction of the
CPT-induced Top1 cleavage product (site 13) in the
unmodiﬁed DNA substrate. In contrast, NaCNBH3
completely suppresses the Top1-mediated DNA cleavage
induced in the CrA-PdG adducted DNA substrate
(Figure 3A, compare lanes 9–12 and lanes 13–16). It is
likely that this inhibition is attributable to the formation
of a stable DNA–protein crosslink between Top1 and the
ring open form of the CrA-PdG adduct (previously shown
in Figure 1A). Taken together, the results presented in
Figure 3 demonstrate that CrA-PdG adduct formation
can both inhibit Top1-mediated DNA cleavage at adduct
sites and induce the formation of new high-aﬃnity Top1
cleavage sites in the near vicinity. Moreover, CrA-PdG
adducts are able to sequester the DNA cleaving activity of
Top1 by trapping the enzyme in a cleavage incompetent
complex via the formation of a stable DNA–Top1
crosslink.
Stability of theCrA-PdG adduct-induced
Top1 cleavage complexes
To further characterize the Top1 cleavage complexes
induced by the CrA-PdG adduct, we investigated whether
these cleavage complexes were reversible using a salt
reversal assay. Indeed, one characteristic of the Top1
cleavage reaction is that in the presence of high salt
concentrations the cleavage–religation equilibrium is
shifted toward religation (34). Religation of the CPT-
induced DNA cleavage site (13-mer) in the unmodiﬁed
DNA substrate was previously demonstrated to be
complete within 10min following the addition of 0.35M
NaCl (Figure 4A and B) (35). More interestingly, whereas
the CPT-sensitive cleavage site at position 18 in the DNA
substrate containing the CrA-PdG adduct had similar
reversal kinetics to that of the complexes trapped by CPT
in the unmodiﬁed DNA substrate (site 13), the cleavage at
the CPT-independent site at position 17, albeit partially
reversible, was much more stable (Figure 4A and B). This
slowing of the religation step generated by the CrA-PdG
adduct is possibly caused by distortion of the DNA
structure and consequent inhibition of the nucleophilic
attack on the tyrosylphophodiester bond by the cleaved
50-hydroxyl DNA strand (see Discussion section).
Detection ofDNA–Top1 covalent complexes
by crotonaldehyde invivo
Finally, to investigate whether Top1 can be trapped by
CrA-PdG adducts in cellular DNA, we employed the
immunocomplex of enzyme (ICE) bioassay. This techni-
que permits the detection of Top1 covalently linked to
genomic DNA through the used of cesium chloride (CsCl)
gradient fractionation and subsequent western blot
analysis (27,28). MCF7 cells were incubated with
100mM of crotonaldehyde for 6h, and the cell extracts
were fractionated by centrifugation with a CsCl gradient.
In untreated control samples, Top1 was found exclusively
in the upper fractions (12–15) of the CsCl gradient as free
protein (Figure 5A). In contrast, in the cells treated with
crotonaldehyde, Top1 was found in the upper fractions as
well as in the fractions near the bottom of the gradient or
the DNA-containing fractions (3–7) (Figure 5A), which is
indicative of the formation of DNA–Top1 covalent
complexes. DNA–Top1 complexes could also be detected
as early as 1h after treatment with 10 mM crotonaldehyde
(Figure 5B). As a positive control, CPT was shown to trap
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Figure 3. Induction of new Top1-mediated DNA cleavage sites on the
DNA strand opposite to the R/S-CrA-PdG adduct. (A) Double-
stranded (ds) control (WT) or R/S-CrA-PdG (R/S) adducted oligo-
nucleotides were 30-end labeled on the scissile strand (upper) with a-
32P
ddATP (shown as
32P-A in B). DNA was then reacted with Top1 and
camptothecin in the presence or absence of NaCNBH3 (50mM). The
size of the fragments generated by Top1 is indicated to the right.
Asterisks indicate the positions of new Top1-mediated DNA cleavage
sites induced by the CrA-PdG adduct. (B) Summary of Top1-mediated
DNA cleavage sites from (A).
4132 Nucleic Acids Research, 2008, Vol. 36, No. 12DNA–Top1 complexes as expected (Figure 5B). These
results suggests that crotonaldehyde can produce stable
cellular DNA adducts, which can subsequently form
DNA–Top1 covalent complexes in vivo, albeit much less
eﬃciently than CPT.
DISCUSSION
Crotonaldehyde is a bifunctional electrophile. An inter-
esting feature of crotonaldehyde is its ability to form
primary DNA adducts that are capable of participating in
secondary reactions with cellular macromolecules. In this
article, we report the induction of DNA–Top1 crosslinks
both directly and indirectly by crotonaldehyde-derived
DNA adducts. In addition, the formation of stable DNA–
Top1 covalent complexes is observed in cells treated with
crotonaldehyde (Figure 5). Thus, the results reported here
suggest that these types of DNA lesions, if unrepaired,
may contribute to some degree to the mutagenic and
carcinogenic consequences of crotonaldehyde exposure.
Initial studies by Kurtz and Lloyd (23) established the
predisposition of CrA-PdG adducts to take part in
secondary reactions with proteins by demonstrating the
formation of crosslinks between CrA-PdG adducts and
the tetrapeptide KWKK. However, further analysis
revealed that the bond formed between the CrA-PdG
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100mM of crotonaldehyde (CrA) for 6h. Equal numbers of cells were
lyzed and separated by CsCl gradients centrifugation. Fractions were
collected from the bottom of the tubes (numbered 1–15). The presence
of Top1 was assayed in each of the gradient fractions by western
blotting with a Top1 monoclonal antibody. Cellular DNA was
contained in fractions 3–7, which corresponds to the DNA–Top1
complexes. (B) MCF7 cells were treated with 0.1mM CPT or 10mM
CrA for 1h. All of the DNA-containing fractions (3–7) were collected
from the CsCl gradient, pooled together, serial diluted and then blotted
with the Top1 monoclonal antibody.
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group and not the e-amino groups of the lysine residues.
The rationalization for this selectivity was based on the
intrinsic lower pKa of the a-amine relative to the e-amino
groups. Nevertheless, the speciﬁc microenvironment in
enzyme active sites can decrease the pKa of lysyl side
chains and eﬀectively render them more nucleophilic. The
related acrolein-dG adduct has been reductively trapped
with histones and the base-excision repair protein
T4 pyrimidine dimer glycosylase (T4 PDG) (36).
Additionally, DNA–protein crosslinks between the alde-
hydic form of an abasic site with a catalytic N-terminal
threonine of T4 PDG have also been trapped by
NaBCNH3 treatment (37,38). In the case of Top1, it has
recently been shown that pyridoxal 50-phosphate can act
as a catalytic inhibitor of Top1 through the formation of a
Schiﬀ base between its aldehydic moiety and the "-amino
group of a critical active site lysine residue (39,40). Indeed,
examination of the available crystal structures of Top1
bound to DNA reveals the presence of several potentially
nucleophilic lysine sidechains within the DNA-binding
pocket capable of forming Schiﬀ base-mediated crosslinks
between CrA-PdG adducts and Top1 (41). It is likely that
there are several diﬀerent populations of crosslinking
residues in Top1. Moreover, besides the "-amino group of
lysine, additional reactive amino acid residues may include
the sulfhydryl group of cysteine and the imidazole group
of histidine.
The propensity of primary CrA-PdG adducts to
participate in secondary reactions is derived from its
ability to undergo a ring-opening reaction from a cyclic,
ring-closed form in single-stranded DNA or nucleosides
into a reactive ring-open aldehydic moiety when paired
opposite dC in a duplex environment (20). Similar ring-
opening reactions have been observed with the related
adducts g-OH-PdG and M1dG (42,43). DNA–Top1
crosslinks only appeared in the presence of the CrA-
PdG adducted duplex DNA substrate (Figure 1B), which
indirectly conﬁrms this structural transformation by
CrA-PdG adducts in duplex DNA. That observation is
consistent with previous ﬁndings that demonstrated a
markedly slower rate of DNA–peptide crosslink forma-
tion for a single-stranded CrA-PdG adducted DNA
substrate compared to a duplex substrate (23). Thus, it
is plausible to envisage that CrA-PdG adducts exist largely
as the ring-open form in vivo by reason of the native
structure of the DNA within the cell is double stranded.
CrA-PdG adducts can also redirect the DNA-cleaving
activity of Top1 to alternative sites (Figure 6B). In this
study, the presence of a single CrA-PdG adduct at the
 3(G) position on the nonscissile strand of the DNA
substrate (Figure 1A) completely suppresses the cleavage
of the high-aﬃnity CPT-dependent Top1 cleavage site
(Figure 3A). This result may partly be explained by steric
clashes between the presence of adducts in the DNA
minor groove and the binding of Top1 (32,33,35). Recent
NMR studies have shown that the CrA-PdG adduct in the
ring-open form occupies the minor groove and extends
toward the 50-end of the adducted strand, overlaying
roughly two adjacent base pairs (26), which correspond to
A( 2) and A( 1) in the Top1 substrate used in these
studies (Figure 1A). This minor groove interference by the
CrA-PdG adduct thus blocks speciﬁc interactions needed
for proper nucleophilic attack by the catalytic tyrosine of
Top1. A similar site-speciﬁc inhibition has been observed
for other minor groove adducts derived from polycyclic
aromatic diol epoxides or acetaldehyde adducts (32,33,35).
Alternatively, the CrA-PdG adduct may restrict CPT from
accessing and stabilizing the Top1 cleavage complex, and
as a result inhibit the formation of the observed DNA
cleavage product (13-mer).
In addition to inhibiting the preferential Top1 cleavage
site, the CrA-PdG adduct also induced the formation of
two new Top1-mediate cleavage sites (17- and 18-mer) in
the absence of CPT upstream of the preferential cleavage
site (13-mer) (Figures 3A and 6). We believe that the
formation of these novel DNA-cleavage sites is due to the
interference of the CrA-PdG adduct with the Top1
binding at the preferential site (13-mer). On the basis of
our previous studies, we presume that Top1 can bind and
interact at several diﬀerent positions on the oligonucleo-
tides (32,33,35), and cleavage at the alternative sites only
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Figure 6. Summary of DNA–Top1 complex formation by (A) unmod-
iﬁed DNA substrate and (B–C) CrA-PdG adducted DNA substrate.
Boxed nucleotide, site of adduct; open triangles, no cleavage; closed
triangles, Top1 cleavage site. (A) In the unmodiﬁed substrate, Top1
cleavage complexes are trapped by CPT at site 13. Sites 17 and 18 are
undetectable. (B) In the CrA-PdG adducted substrate, site 13 is
suppressed and two cleavage sites are induced; site 17 is CPT-
independent and site 18 is trapped by CPT. (C) Upon reduction by
NaCNBH3, Top1 forms an indirect crosslink with the DNA via the
CrA-PdG adduct and the formation of Top1 cleavage complexes is
inhibited.
4134 Nucleic Acids Research, 2008, Vol. 36, No. 12becomes kinetically favored when cleavage at the prefer-
ential site is inhibited, which is the case when the CrA-
PdG adduct is present. Interestingly, both the 18-mer
cleavage product in the adducted DNA substrate and the
expected 13-mer cleavage product in the unmodiﬁed
substrate contain similar features. First, both cleavage
sites are enhanced by the addition of CPT. Second, each
contain a guanine immediately 30 to the cleaved bond
(Figures 3B and 6), which is consistent with previous
studies showing that CPT predominantly traps Top1
cleavage sites of this sequence context (44). Lastly, both
have comparable religation kinetics (Figure 4B). Of
greater interest is the auxiliary cleavage site (17-mer)
that is induced by the CrA-PdG adduct. This cleavage site
is unaﬀected by CPT treatment and exhibits slowed
religation kinetics in comparison (Figure 4B) to the
previously mentioned Top1 cleavage sites. The ﬁrst
characteristic is almost certainly due to the identity of
the DNA bases around the cleavage site, whereas the
second is most likely due to the distortion of the DNA
structure after Top1 has cleaved the DNA backbone.
Overall, our interpretation is that the factors eﬀecting the
induction of the two diﬀerent populations of Top1
cleavage are based on: (i) geometrical changes in the
DNA caused by the CrA-PdG adduct and (ii) on the
selective trapping by CPT of the site bearing a guanine +1
(site producing the 18-mer) (44), which provides prefer-
ential binding for the drug (Figure 6B).
The presence of a reducing agent in the cleavage
reactions presented here results in complete inhibition of
the CrA-PdG induced cleavage sites, which suggests that
the induction of Top1 cleavage complexes by CrA-PdG
adducts and formation of a stable bona ﬁde DNA–Top1
crosslinks at the site of the CrA-PdG adduct are mutually
exclusive (Figure 6B and C). In other words, we propose
that the Top1 cannot be bound to the DNA more than
once in the presence of the CrA-PdG adduct. More
speciﬁcally, Top1 is either bound at the alternative
cleavage site on the DNA through its active site tyrosine
to form a cleavage complex or bound to the CrA-PdG
adduct through a given lysine residue to form a DNA–
protein crosslink.
Alterations in Top1 enzymatic activities are not limited
to the occurrence of CrA-PdG adducts. Other similar
covalent DNA adducts that lie within the minor groove,
such as the benzo[a]pyrene or benzo[c]phenanthrene diol
epoxide (BaP and BcPh, respectively) adducts (32,33), or
the acetaldehyde adduct (35), have been shown to both
enhance as well as suppress Top1 cleavage depending on
the position of the adduct relative to the cleavage site.
Analogous to CrA-PdG adducts, BaP and BcPh adducts
are dominant inducers of new Top1 cleavages (32,33). In
addition, the noncovalent minor groove binding drug,
ecteinascidin 743, can also inﬂuence the catalytic cycle of
Top1 by inhibiting the DNA religation step (i.e. poisoning
Top1) (45). Together with the present results obtained
with the CrA-PdG adduct, these studies highlight the
importance of the contacts between the DNA minor
groove and the catalytic active site of Top1.
Although we are unable to discriminate between what
types of DNA–Top1 covalent complexes are induced by
crotonaldehyde in mammalian cells (Figure 5), both
lesions have the potential to be damaging in vivo.O f
interest is the recent study showing that crotonaldehyde
treated mice exhibit an increase in the frequency of
chromosomal aberrations (46). These cytogenetic eﬀects
of crotonaldehyde are reminiscent of the chromosomal
abnormalities observed after the stabilization of DNA–
Top1 cleavage complexes with Top1 poisons, such as
CPT. On the basis of the results of the present investiga-
tion, it might be concluded that the harmful eﬀects of
crotonaldehyde exposure may to a degree stem from the
direct and indirect formation of DNA–Top1 covalent
complexes, which can lead to DNA damage if unrepaired.
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